Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-26-035615

CEO and President gave up 14 shares (to pay taxes)

  • CEO and President acquired 57 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

KLEMP WALTER V · CEO and President

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-04 Exercise or conversion : show line 1 in the form +57 36,217 D
2026-11-04 Shares withheld for taxes : show line 2 in the form −14 $8.46 $118 36,203 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-11-04 Exercise or conversion : show line 3 in the form Restricted Stock Units −57 127,415 D
Loading xslF345X06/rdgdoc.xml…